D B A Silk
Datos Biográficos
| ID | 10212413 |
|---|---|
| NOMBRE | D B A Silk |
| NOMBRES | D B A |
| APELLIDO | Silk |
| FIRMA | SILK D B A |
| AFILIACIONES | UNSW Sydney |
| ORCID | 0000-0001-6931-8138 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 9 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 9 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2021 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Service provider perceptions of incorporating hepatitis C testing technologies into standard practice
The expansion of HCV testing and care necessitates that more structural support (e.g., adequate funding and staffing) be offered to service providers. Despite the adaptability of providers, a one-size-fits-all approach will not suit the needs of all settings
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia
Findings highlight the importance of offering rapid, staff-assisted HCV testing to improve uptake among at-risk populations
Needle and syringe sharing among people who have recently injected drugs in Australia
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs
Among 2,395 participants enrolled in ETHOS Engage, 66% (n = 1,591) were men, 33% (n = 786) women, and <1% (n = 18) did not identify as a man or woman. HCV testing history and current infection were similar among men and women. Among men or women ever eligible for HCV treatment (ever chronic HCV) (n = 1,242), women were less likely to report a history of HCV treatment compared to men (227/352, 64% vs. 631/890, 71%; p = 0.03). Among women, those ag…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Sin obras prominentes en esta página.
Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia
Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy
Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs
Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia
Needle and syringe sharing among people who have recently injected drugs in Australia
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs
Among 2,395 participants enrolled in ETHOS Engage, 66% (n = 1,591) were men, 33% (n = 786) women, and <1% (n = 18) did not identify as a man or woman. HCV testing history and current infection were similar among men and women. Among men or women ever eligible for HCV treatment (ever chronic HCV) (n = 1,242), women were less likely to report a history of HCV treatment compared to men (227/352, 64% vs. 631/890, 71%; p = 0.03). Among women, those ag…
Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs
Results highlight important intersections and disparities in stigmatising experiences among people who inject drugs. Considering these intersections can assist health services provide more inclusive care
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia
Findings highlight the importance of offering rapid, staff-assisted HCV testing to improve uptake among at-risk populations
Service provider perceptions of incorporating hepatitis C testing technologies into standard practice
The expansion of HCV testing and care necessitates that more structural support (e.g., adequate funding and staffing) be offered to service providers. Despite the adaptability of providers, a one-size-fits-all approach will not suit the needs of all settings
Medicine (8 obras) · Hepatitis C virus research (7 obras) · HIV, Drug Use, Sexual Risk (6 obras) · Internal Medicine (6 obras) · Hepatitis C (5 obras) · Hepatitis B Virus Studies (4 obras) · Human immunodeficiency virus (HIV (4 obras) · Logistic regression (4 obras) · Cohort (3 obras) · Environmental health (3 obras)